Detalles de la búsqueda
1.
Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
Clin Infect Dis
; 68(2): 213-221, 2019 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846534
2.
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
J Hepatol
; 65(3): 509-16, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27210427
3.
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.
J Antimicrob Chemother
; 69(1): 12-20, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23934770
4.
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
Antimicrob Agents Chemother
; 57(9): 4290-4299, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23796938
5.
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
J Antimicrob Chemother
; 68(2): 414-8, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23085775
6.
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.
Antimicrob Agents Chemother
; 56(8): 4522-4, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22664973
7.
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.
Antimicrob Agents Chemother
; 56(5): 2305-13, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22330916
8.
Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes.
AIDS Res Ther
; 9(1): 13, 2012 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22554313
9.
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector.
Antimicrob Agents Chemother
; 54(2): 934-6, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19917747
10.
HIV-1 protease mutations and protease inhibitor cross-resistance.
Antimicrob Agents Chemother
; 54(10): 4253-61, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660676
11.
Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens.
Open Forum Infect Dis
; 7(9): ofaa316, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32904894
12.
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
Antimicrob Agents Chemother
; 53(5): 2196-8, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19223644
13.
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.
Antimicrob Agents Chemother
; 53(11): 4869-78, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19721070
14.
Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
Antivir Ther
; 14(2): 273-83, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19430102
15.
Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.
J Virol
; 82(21): 10747-55, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18715933
16.
Virologic efficacy of boosted double versus boosted single protease inhibitor therapy.
AIDS
; 21(12): 1547-54, 2007 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-17630549
17.
Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance.
Antivir Ther
; 12(2): 169-78, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17503659
18.
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.
Sci Rep
; 7(1): 11559, 2017 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28912582
19.
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
AIDS Res Hum Retroviruses
; 22(12): 1300-5, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17209774
20.
Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance.
J Acquir Immune Defic Syndr
; 72(2): 171-6, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26855248